Versant Ventures — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Aset TherapeuticsMar 2017SEC filingmedium confidence
BiotechStony Brook, US
Elizabeth Buck(Executive Officer)Garry E Menzel(Director)David M Epstein(Executive Officer, Director)Alexander Mayweg(Director)
Board seatBrad BolzonAlex Mayweg· per SEC Form D · $12.1M raise · filed Jan 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.